LEVETIRACETAM DEXCEL 1000

Negara: Israel

Bahasa: Inggris

Sumber: Ministry of Health

Beli Sekarang

Selebaran informasi Selebaran informasi (PIL)
22-11-2021

Bahan aktif:

LEVETIRACETAM

Tersedia dari:

DEXCEL PHARMA TECHNOLOGIES LTD

Kode ATC:

N03AX14

Bentuk farmasi:

TABLETS

Komposisi:

LEVETIRACETAM 1000 MG

Rute administrasi :

PER OS

Jenis Resep:

Required

Diproduksi oleh:

DEXCEL LTD, ISRAEL

Kelompok Terapi:

LEVETIRACETAM

Area terapi:

LEVETIRACETAM

Indikasi Terapi:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Tanggal Otorisasi:

2018-03-31

Dokumen dalam bahasa lain

Selebaran informasi Selebaran informasi Arab 22-11-2021
Selebaran informasi Selebaran informasi Ibrani 09-10-2023

Peringatan pencarian terkait dengan produk ini